A1410
|
Actinomycin D from Streptomyces sp., ~98% (HPLC)
|
|
|
A9415
|
Actinomycin D from Streptomyces sp., suitable for cell culture, ≥95%
|
|
|
A4262
|
Actinomycin D from Streptomyces sp., ≥95% (HPLC)
|
|
|
A5156
|
Actinomycin D–Mannitol lyophilized powder
|
|
|
A6671
|
Actinonin
|
|
|
05260
|
L-Alanyl-L-1-aminoethylphosphonic acid ≥95% (HPLC)
|
|
|
A1276
|
Amastatin hydrochloride hydrate ≥97% (HPLC)
|
|
|
A1774
|
Amikacin disulfate salt potency: 674-786 μg per mg (as amikacin base)
|
|
|
A3650
|
Amikacin hydrate aminoglycoside antibiotic
|
|
|
A2324
|
Amikacin sulfate salt aminoglycoside antibiotic
|
|
|
A9400
|
7-Aminoactinomycin D ~97% (HPLC), powder
|
|
|
191140
|
7-Aminocephalosporanic acid 98%
|
|
|
A8398
|
7-Aminodesacetoxycephalosporanic acid
|
|
|
A70909
|
(+)-6-Aminopenicillanic acid 96%
|
|
|
A8523
|
Amoxicillin potency: ≥900 μg per mg
|
|
|
A5354
|
Ampicillin Ready Made Solution, 100 mg/mL, 0.2 μm filtered
|
|
|
A9393
|
Ampicillin anhydrous, 96.0-102.0% (anhydrous basis)
|
|
|
A1593
|
Ampicillin meets USP testing specifications
|
|
|
A9518
|
Ampicillin sodium salt
|
|
|
A0166
|
Ampicillin sodium salt powder or crystals, BioReagent, suitable for cell culture
|
|
|
A8351
|
Ampicillin sodium salt BioXtra, suitable for cell culture
|
|
|
A6140
|
Ampicillin trihydrate 900-1050 μg/mg anhydrous basis (HPLC)
|
|
|
A2024
|
Apramycin sulfate salt
|
|
|
A2385
|
5-Azacytidine ≥98% (HPLC)
|
|
|
A1287
|
5-Azacytidine Hybri-Max™, γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma
|
|
|
75199
|
Azithromycin
|
|
|
A7926
|
Azlocillin sodium salt
|
|
|
A6848
|
Aztreonam analytical standard
|
|
|
B0125
|
Bacitracin from Bacillus licheniformis, ≥65 IU/mg
|
|
|
11702
|
Bacitracin from Bacillus licheniformis, ≥60000 U/g (Potency)
|
|
|
B8800
|
Bacitracin zinc salt from Bacillus licheniformis, meets USP testing specifications
|
|
|
B5150
|
Bacitracin zinc salt from Bacillus licheniformis, ~70,000 U/g
|
|
|
B2809
|
Bactenecin ≥95% (HPLC)
|
|
|
11707
|
Bafilomycin B1 from Streptomyces sp. ≥80% (HPLC)
|
|
|
SRP3013
|
Beta D-4 human recombinant, expressed in E. coli, ≥98% (HPLC), suitable for cell culture
|
|
|
SRP3011
|
Beta D-1 (36 aa) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
|
|
|
SRP3012
|
Beta D-1 (47 aa) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
|
|
|
15205
|
Blasticidine S hydrochloride
|
|
|
B3061
|
Borrelidin from Streptomyces parvulus, ≥98% (HPLC)
|
|
|
B7651
|
Brefeldin A from Penicillium brefeldianum, ≥99% (HPLC and TLC)
|
|
|
B6542
|
Brefeldin A ≥99% (HPLC and TLC), BioXtra, for molecular biology
|
|
|
B8791
|
5-Bromo-5-nitro-1,3-dioxane ≥99%
|
|
|
21186
|
Calcium ionophore III Selectophore™, function tested
|
|
|
C7522
|
Calcium Ionophore A23187 ≥98% (TLC), powder
|
|
|
C9275
|
Calcium Ionophore A23187 hemicalcium salt powder
|
|
|
C9400
|
Calcium Ionophore A23187 hemimagnesium salt
|
|
|
C4142
|
Capreomycin sulfate from Streptomyces capreolus antibacterial peptide
|
|
|
C1613
|
Carbenicillin Ready Made Solution, 100 mg/mL in ethanol/water, 0.2 μm filtered
|
|
|
C9231
|
Carbenicillin disodium meets USP testing specifications
|
|
|
C1389
|
Carbenicillin disodium salt 89.0-100.5% anhydrous basis
|
|
|
C3416
|
Carbenicillin disodium salt BioReagent, suitable for plant cell culture
|
|
|
C6830
|
Cecropin A ≥97% (HPLC), powder
|
|
|
C1796
|
Cecropin B ≥97% (HPLC), powder
|
|
|
C7927
|
Cecropin P1 Porcine ≥95% (HPLC), powder
|
|
|
C6895
|
Cefaclor
|
|
|
33989
|
Cefalexin VETRANAL®, analytical standard
|
|
|
C5020
|
Cefazolin sodium salt 89.1-110.1%
|
|
|
C7118
|
Cefdinir ≥97.0% (HPLC)
|
|
|
C6048
|
Cefmetazole sodium salt
|
|
|
C4292
|
Cefoperazone sodium salt 870-1015 μg/mg (anhydrous basis)
|
|
|
C7039
|
Cefotaxime sodium salt suitable for plant cell culture, BioReagent, powder
|
|
|
C7912
|
Cefotaxime sodium salt potency: 916-964 μg per mg
|
|
|
C8145
|
Cefsulodin sodium salt hydrate third-generation cephalosporin antibiotic
|
|
|
C3809
|
Ceftazidime hydrate ≥90.0%, contains ~10% sodium carbonate as stabilizer
|
|
|
C5793
|
Ceftriaxone disodium salt hemi(heptahydrate) third-generation cephalosporin antibiotic
|
|
|
C4895
|
Cephalexin hydrate first-generation cephalosporin antibiotic
|
|
|
C4520
|
Cephalothin sodium salt
|
|
|
C8395
|
Cephradine ≥90.0% (Cephradine, HPLC)
|
|
|
C0732
|
Cetylpyridinium chloride meets USP testing specifications
|
|
|
C0378
|
Chloramphenicol ≥98% (HPLC)
|
|
|
C1919
|
Chloramphenicol BioReagent, suitable for plant cell culture
|
|
|
C0857
|
Chloramphenicol meets USP testing specifications
|
|
|
C3787
|
Chloramphenicol succinate sodium salt ≥80% (HPLC)
|
|
|
C6143
|
Chlorhexidine diacetate salt hydrate bis(biguanide) antimicrobial
|
|
|
C9394
|
Chlorhexidine digluconate solution 20% in H2O
|
|
|
C4881
|
Chlortetracycline hydrochloride ≥91.0% dry basis (HPLC)
|
|
|
46133
|
Chlortetracycline hydrochloride VETRANAL®, analytical standard
|
|
|
26430
|
Chlortetracycline hydrochloride BioReagent, suitable for fluorescence, from Streptomyces aureofaciens, ≥97.0% (AT)
|
|
|
17776
|
Chlortetracycline Selective Supplement for microbiology
|
|
|
C6616
|
Chrysomycin A ≥98% (HPLC), solid
|
|
|
C6491
|
Chrysomycin B ≥98% (HPLC), solid
|
|
|
C8645
|
Cinoxacin
|
|
|
17850
|
Ciprofloxacin ≥98% (HPLC)
|
|
|
C9742
|
Clarithromycin ≥95% (HPLC)
|
|
|
C5269
|
Clindamycin hydrochloride lincosamide antibiotic
|
|
|
C6427
|
Clindamycin 2-phosphate aminoglycoside antibiotic
|
|
|
C8895
|
Clofazimine
|
|
|
27555
|
Cloxacillin sodium salt ≥95.0% (HPLC)
|
|
|
C9393
|
Cloxacillin sodium salt monohydrate β-lactamase-resistant antibiotic
|
|
|
C4461
|
Colistin sulfate salt ≥19,000 IU/mg
|
|
|
C1511
|
Colistin sodium methanesulfonate ~11,500 U/mg
|
|
|
27655
|
Colistin sodium methanesulfonate from Bacillus colistinus
|
|
|
C6880
|
D-Cycloserine
|
|
|
30020
|
D-Cycloserine
|
|
|
C3909
|
D-Cycloserine synthetic
|
|
|
30450
|
Daunorubicin hydrochloride ≥90% (HPLC)
|
|
|
D2043
|
Defensin HNP-1 human ≥80% (HPLC)
|
|
|
D6790
|
Defensin HNP-2 human ≥95% (HPLC)
|
|
|
D6140
|
Demeclocycline hydrochloride powder or crystals
|
|
|
D2141
|
6-Diazo-5-oxo-L-norleucine crystalline
|
|
|
D9016
|
Dicloxacillin sodium salt monohydrate
|
|
|
D7253
|
Dihydrostreptomycin sesquisulfate
|
|
|
D5155
|
Dihydrostreptomycin sesquisulfate BioReagent, suitable for cell culture, ≥95.0% (HPLC)
|
|
|
D7770
|
Diminazene aceturate analytical standard
|
|
|
D4065
|
Dirithromycin analytical standard, for drug analysis
|
|
|
D9891
|
Doxycycline hyclate
|
|
|
33429
|
Doxycycline hyclate VETRANAL®, analytical standard
|
|
|
D3168
|
Duramycin from Streptoverticillium cinnamoneus ≥90.0%
|
|
|
E7280
|
Elafin human >90% (by MS, HPLC and SDS-PAGE), recombinant, expressed in Saccharomyces cerevisiae
|
|
|
E1406
|
Embelin ≥98% (HPLC), powder
|
|
|
17849
|
Enrofloxacin ≥99.0% (HPLC)
|
|
|
33699
|
Enrofloxacin VETRANAL®, analytical standard
|
|
|
E5389
|
Erythromycin BioReagent, suitable for cell culture
|
|
|
E6376
|
Erythromycin potency: ≥850 μg per mg
|
|
|
E0774
|
Erythromycin meets USP testing specifications
|
|
|
45674
|
Erythromycin tested according to Ph. Eur.
|
|
|
E8755
|
Erythromycin ethyl succinate
|
|
|
45703
|
Erythromycin standard solution 1 mg/mL in H2O
|
|
|
E4630
|
Ethambutol dihydrochloride antimycobacterial
|
|
|
F1427
|
Florfenicol analytical standard, for drug analysis
|
|
|
F7016
|
Flumequine ≥97.0% (HPLC)
|
|
|
45735
|
Flumequine VETRANAL®, analytical standard
|
|
|
F9505
|
Furazolidone
|
|
|
46297
|
Furazolidone VETRANAL®, analytical standard
|
|
|
F6513
|
Fusaric acid from Gibberella fujikuroi
|
|
|
F0881
|
Fusidic acid sodium salt ≥98% (TLC)
|
|
|
A1720
|
G 418 disulfate salt powder, BioReagent, suitable for cell culture
|
|
|
G5013
|
G 418 disulfate salt potency: ≥450 μg per mg (dried basis)
|
|
|
G1279
|
G 418 disulfate salt suitable for plant cell culture, BioReagent
|
|
|
G8168
|
G 418 disulfate salt solution 50 mg/mL in H2O, sterile-filtered, BioReagent, suitable for cell culture
|
|
|
G1397
|
Gentamicin solution 50 mg/mL in deionized water, liquid, sterile-filtered, BioReagent, suitable for cell culture
|
|
|
G1272
|
Gentamicin solution 10 mg/mL in deionized water, liquid, sterile-filtered, BioReagent, suitable for cell culture
|
|
|
G1522
|
Gentamicin solution Hybri-Max™, sterile-filtered, 50 mg/mL gentamicin, BioReagent, suitable for hybridoma
|
|
|
G1914
|
Gentamicin sulfate meets USP testing specifications, powder
|
|
|
G4918
|
Gentamicin sulfate meets EP, USP testing specifications
|
|
|
48760
|
Gentamicin sulfate from Micromonospora purpurea ≥590 μg/mg of gentamicin
|
|
|
G1264
|
Gentamicin sulfate salt powder, BioReagent, suitable for cell culture
|
|
|
G3632
|
Gentamicin sulfate salt potency: ≥590 μg Gentamicin base per mg
|
|
|
G9654
|
Gentamicin-Glutamine solution with 200 mM L-glutamine and 5 mg gentamicin per mL in tissue culture grade water, liquid, sterile-filtered, BioReagent, suitable for cell culture
|
|
|
G9893
|
Gliotoxin from Gliocladium fimbriatum
|
|
|
G6784
|
L-Glutamine–Penicillin–Streptomycin solution L-glutamine 200 mM, penicillin 10,000 units, streptomycin 10 mg/mL, sterile-filtered, BioReagent, suitable for cell culture
|
|
|
G1146
|
L-Glutamine–Penicillin–Streptomycin solution with 200 mM L-glutamine, 10,000 U penicillin and 10 mg steptomycin/mL in 0.9% NaCl, sterile-filtered, BioReagent, suitable for cell culture
|
|
|
G5002
|
Gramicidin from Bacillus aneurinolyticus (Bacillus brevis) Linear polypeptide antibiotic complex. A mixture of gramicidins A, B, C, and D.
|
|
|
50845
|
Gramicidin A from Bacillus brevis
|
|
|
50847
|
Gramicidin C from Bacillus brevis ~90% (HPLC)
|
|
|
H4914
|
Honokiol ≥98% (HPLC), powder
|
|
|
252565
|
8-Hydroxyquinoline ACS reagent, 99%
|
|
|
H6878
|
8-Hydroxyquinoline crystalline
|
|
|
I0160
|
Imipenem monohydrate ≥98% (HPLC)
|
|
|
I0634
|
Ionomycin calcium salt from Streptomyces conglobatus powder, ≥98% (HPLC)
|
|
|
I9657
|
Ionomycin from Streptomyces conglobatus ≥98% (HPLC)
|
|
|
72779
|
Irgasan 97.0-103.0% (active substance, GC)
|
|
|
I3377
|
Isoniazid analytical standard, ≥99% (TLC)
|
|
|
59983
|
Josamycin ≥90% (HPLC)
|
|
|
K1876
|
Kanamycin disulfate salt from Streptomyces kanamyceticus aminoglycoside antibiotic
|
|
|
K0254
|
Kanamycin solution from Streptomyces kanamyceticus 50 mg/mL in 0.9% NaCl, BioReagent, liquid, sterile-filtered, suitable for cell culture
|
|
|
K0129
|
Kanamycin solution from Streptomyces kanamyceticus 10 mg/mL in 0.9% NaCl, sterile-filtered, BioReagent, suitable for cell culture
|
|
|
K1377
|
Kanamycin sulfate from Streptomyces kanamyceticus powder, BioReagent, suitable for cell culture, suitable for plant cell culture
|
|
|
K4000
|
Kanamycin sulfate from Streptomyces kanamyceticus Animal Component-free
|
|
|
K1637
|
Kanamycin sulfate from Streptomyces kanamyceticus meets USP testing specifications, powder
|
|
|
B5264
|
Kanamycin B sulfate salt aminoglycoside antibiotic
|
|
|
60615
|
Kanamycin sulfate mixture of Kanamycin A (main component) and Kanamycin B and C
|
|
|
K4013
|
Kasugamycin hydrochloride from Streptomyces kasugaensis ≥90% (HPLC)
|
|
|
K1513
|
Kendomycin from Streptomyces violaceoruber solid
|
|
|
K1507
|
Kirromycin from Streptomyces collinus
|
|
|